Related Experiment Videos

Pyoderma gangrenosum: a possible cutaneous complication of levamisole-tainted cocaine abuse

Phillip J Keith¹, Joel C Joyce², Barbara D Wilson²

¹Department of Dermatology, Mayo Clinic, Rochester, MN, USA.

International Journal of Dermatology

|June 6, 2014

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Safety and Tolerability of Ruxolitinib Cream in Adolescents with Mild-to-Moderate Atopic Dermatitis: Results From a 1-Year, Phase III, Open-Label Study.

American journal of clinical dermatology·2026

Summary of Research: Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry.

Dermatology and therapy·2026

Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry.

American journal of clinical dermatology·2025

Real-world treatment outcomes of systemic treatments for moderate-to-severe atopic dermatitis in children aged less than 12 years: 2-year results from PEDIatric STudy in Atopic Dermatitis.

Journal of the American Academy of Dermatology·2024

Pediatric dermatofibromas: Truncal predominance in younger children.

Pediatric dermatology·2024

Updates in atopic dermatitis for the primary care physician: A review of advances in the understanding and treatment of atopic dermatitis.

Disease-a-month : DM·2024

See all related articles